Aim & Scope
Annals of Leukemia Research (ALR) is a peer-reviewed, open-access journal published by Somato Publications. It publishes research on the biology, diagnosis and treatment of leukaemia and related blood cancers.
Clinical trials, translational studies and well-documented case reports are all welcome, as is work on supportive care and survivorship.
Scope
ALR publishes original research articles, review articles, case reports and short communications in areas including, but not limited to:
- Acute and chronic leukaemias
- Myelodysplastic and myeloproliferative disorders
- Molecular diagnostics and minimal residual disease
- Chemotherapy, targeted and immunotherapies
- Stem cell and bone marrow transplantation
- CAR-T and cellular therapies
- Paediatric leukaemia
- Infection and supportive care
- Epidemiology and outcomes
Peer Review
Every submission goes through double-blind peer review by at least two independent reviewers with expertise in the subject. The usual time from submission to first editorial decision is 12–14 weeks. See the Peer Review Policy for details.
Originality
All manuscripts are screened for similarity with iThenticate before they go to reviewers, as set out in the Plagiarism Policy.
Open Access and Licensing
ALR is fully open access. Authors keep the copyright in their work, which is published under a Creative Commons Attribution 4.0 International License (CC BY 4.0).
Article Processing Charges
There is no Article Processing Charge. Annals of Leukemia Research charges authors nothing at any stage of submission, peer review or publication.
